Article Text

Download PDFPDF

Original research
Current evidence for anesthesia management during endovascular stroke therapy: updated systematic review and meta-analysis
Free
  1. Nitin Goyal1,
  2. Konark Malhotra2,
  3. Muhammad F Ishfaq1,
  4. Georgios Tsivgoulis1,3,
  5. Christopher Nickele4,
  6. Daniel Hoit4,
  7. Adam S Arthur4,
  8. Andrei V Alexandrov4,
  9. Lucas Elijovich1,4
  1. 1 Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
  2. 2 Department of Neurology, West Virginia University-Charleston Division, Charleston, West Virginia, USA
  3. 3 Second Department of Neurology, “Attikon University Hospital”, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece
  4. 4 Department of Neurosurgery, University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee, USA
  1. Correspondence to Dr. Nitin Goyal, Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA; ngoyal{at}uthsc.edu

Abstract

Introduction Debate continues about the optimal anesthetic management for patients undergoing endovascular treatment (ET) of acute ischemic stroke due to emergent large vessel occlusion.

Objective To compare, using current evidence, the clinical outcomes and procedural characteristics among patients undergoing general anesthesia (GA) and local or monitored anesthesia (non-GA).

Methods We performed a systematic review and meta-analysis of all available studies that involved the use of stent retrievers for ET (stentriever group). Additionally, we included studies that were published in 2015 and later, and compared the clinical outcomes among the studies using stentrievers or no stentrievers (pre-stentriever group). Outcome variables included functional independence (FI; modified Rankin Scale scores of 0–2), symptomatic hemorrhage, mortality, procedure duration, and vascular and respiratory complications. We calculated pooled odds ratios and 95% CIs using random-effects models.

Results Sixteen studies (three randomized controlled clinical trials (RCTs) and 13 non-randomized studies) were identified comprising 5836 patients. Although non-GA was associated with higher odds of 3-month FI (OR=1.57; 95% CI 1.17 to 2.10; P=0.003) and lower odds of 3-month mortality (OR=0.62; 95% CI 0.47 to 0.82; P=0.0006, substantial heterogeneity was noted across included trials. Sensitivity analyses of RCTs showed that non-GA was inversely associated with FI (OR=0.55; 95% CI 0.34 to 0.89; P=0.01; I2=15%), while no association was noted with mortality (OR=1.36; 95% CI 0.79 to 2.34; P=0.27; I2=0%).

Conclusion Our updated meta-analysis demonstrates favorable results with non-GA, probably owing to inclusion of non-randomized studies. Recent single-center RCTs indicate that GA is associated with higher odds of FI at 3 months, while other outcomes are similar between the two groups.

  • anesthesia
  • stroke
  • outcomes
  • intubation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • NG and KM contributed equally.

  • Contributors NG, KM: Study concept and design, acquisition of data, analysis and interpretation, critical revision of the manuscript for important intellectual content. MFI: acquisition of data, critical revision of the manuscript for important intellectual content. GT, CN, DH, ASA, AVA, LE: critical revision of the manuscript for important intellectual content.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.